Markets:

Overview

News

Currencies

International

Treasuries

QuidelOrtho Corporation - Common Stock (NQ:QDEL)

16.34 +1.08 (+7.04%)

Streaming Delayed Price Updated: 2:23 PM EDT, Mar 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about QuidelOrtho Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

Via StockStory

Rice Hall James Buys QuidelOrtho Stock ↗

March 09, 2026

QuidelOrtho develops diagnostic technologies for healthcare providers worldwide, spanning labs, clinics, and retail settings.

Via The Motley Fool

Topics Regulatory Compliance

3 Unprofitable Stocks That Concern Us

March 09, 2026

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure. Finding...

Via StockStory

QuidelOrtho Corp (NASDAQ:QDEL) Beats Q4 Earnings Estimates Despite After-Hours Stock Decline ↗

February 11, 2026

Via Chartmill

QuidelOrtho Corp (NASDAQ:QDEL) Shows High-Quality Technical Breakout Setup ↗

January 06, 2026

Via Chartmill

PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know

March 06, 2026

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the hea...

Via StockStory

Topics Economy

QuidelOrtho (QDEL): Buy, Sell, or Hold Post Q4 Earnings?

March 02, 2026

Over the past six months, QuidelOrtho’s shares (currently trading at $22.11) have posted a disappointing 19.9% loss, well below the S&P 500’s 6.6% gain. This...

Via StockStory

Topics Stocks

QuidelOrtho Corp Director Purchases 10k Shares as CFO Retires ↗

March 01, 2026

QuidelOrtho Corporation's stock has been falling for multiple years, but after a board member purchased shares, could the stock soon reverse?

Via The Motley Fool

Topics Regulatory Compliance Retirement Workforce

Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

February 23, 2026

A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court...

Via StockStory

Topics Economy Government World Trade

1 Russell 2000 Stock to Keep an Eye On and 2 We Brush Off

February 22, 2026

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these...

Via StockStory

Vistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture Bet ↗

February 22, 2026

Vistance Networks delivers connectivity and network solutions for telecom, data centers, and enterprise clients worldwide.

Via The Motley Fool

Array Stock Down 25%, But This $17.3 Million Buy Signals Confidence Amid Big Revenue Growth ↗

February 22, 2026

Array Digital Infrastructure delivers wireless services and device sales to consumers, businesses, and government clients nationwide.

Via The Motley Fool

Topics Regulatory Compliance

Enviri Stock Up 120% as $43 Million Buy Makes It a Top Holding in This Portfolio ↗

February 22, 2026

Enviri delivers environmental and specialty waste solutions for industrial clients through long-term contracts and value-added products.

Via The Motley Fool

Topics Regulatory Compliance

Integer Stock Down 38%, but One Fund Just Bet $40 Million on a Turnaround ↗

February 22, 2026

Integer Holdings supplies medical device components and finished products to major OEMs in cardiac, neuro, and surgical markets.

Via The Motley Fool

Topics Regulatory Compliance

3 Small-Cap Stocks We Approach with Caution

February 18, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

The Top 5 Analyst Questions From QuidelOrtho’s Q4 Earnings Call

February 18, 2026

QuidelOrtho’s fourth quarter was marked by improved operational efficiency and growth in its core labs and non-respiratory businesses, but the market responded negatively to its results. Management...

Via StockStory

Topics Earnings World Trade

QDEL Stock Slumps On Mixed Wall Street Price Target Revisions After Q4 Report ↗

February 12, 2026

UBS, Citi and JPMorgan revised their price targets on the stock on the heels of the company issuing fresh guidance for fiscal 2026.

Via Stocktwits

Topics Artificial Intelligence

QDEL Q4 Deep Dive: Margin Expansion, R&D Pipeline, and Guidance Disappoints

February 12, 2026

Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 2.2% year on year to $723.6 million. The company’s...

Via StockStory

Topics Economy World Trade

QuidelOrtho (QDEL) Q4 2025 Earnings Transcript ↗

February 11, 2026

QuidelOrtho (QDEL) Q4 2025 Earnings Transcript

Via The Motley Fool

Topics World Trade

QuidelOrtho (NASDAQ:QDEL) Exceeds Q4 CY2025 Expectations

February 11, 2026

Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.2% year on year to $723.6 million. The company’s...

Via StockStory

Earnings To Watch: QuidelOrtho (QDEL) Reports Q4 Results Tomorrow

February 09, 2026

Healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) will be reporting earnings this Wednesday after the bell. Here’s what to expect.

Via StockStory

Topics World Trade

3 Volatile Stocks We’re Skeptical Of

February 01, 2026

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced...

Via StockStory

3 Stocks Under $50 Walking a Fine Line

January 29, 2026

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...

Via StockStory

3 Reasons to Sell QDEL and 1 Stock to Buy Instead

January 28, 2026

Since July 2025, QuidelOrtho has been in a holding pattern, posting a small return of 4.6% while floating around $26.60.

Via StockStory

3 Reasons QDEL is Risky and 1 Stock to Buy Instead

January 27, 2026

QuidelOrtho trades at $27.60 per share and has stayed right on track with the overall market, gaining 5.8% over the last six months. At the same time, the S&P 500 has returned 8.8%.

Via StockStory

Topics Stocks

QuidelOrtho (NASDAQ:QDEL) Q3 Earnings: Leading The Medical Devices & Supplies - Imaging, Diagnostics Pack

December 11, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at medical devices & supplies - imaging,...

Via StockStory

Topics Artificial Intelligence

Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake? ↗

December 07, 2025

A newly public real-estate platform is putting up numbers that look far more seasoned than its age.

Via The Motley Fool

Topics Regulatory Compliance

Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock ↗

December 07, 2025

One fund just made a bold bet on a telecom stock undergoing a big transformation

Via The Motley Fool

Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge ↗

December 07, 2025

This fund just doubled down on a stock that’s suddenly delivering the earnings momentum it’s promised for years.

Via The Motley Fool

Topics Regulatory Compliance

Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs ↗

December 07, 2025

A beaten-down diagnostics stock is quietly tightening margins and drawing fresh institutional conviction—here’s what that means for long-term investors.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.